MedPath

Feasability Assessment of wearable sensors for continuous ambulatory vital signs monitoring

Completed
Conditions
Dit betreft een validatie studie van continue metingen van vitale functies, welke niet gerelateerd is aan een enkele aandoening of orgaansysteem
Not applicable
Registration Number
NL-OMON48983
Lead Sponsor
Divisie Vitale Functies
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

Study 1
10 volunteers of both sexes (*18 years of age) are eligible for enrolment, with
the following criteria:
* 5 volunteers need to be at age 65 or above
* 3 volunteers need to have a BMI >30 kg/m2, Study 2
10 volunteers ( *18 years of age) are eligible for enrolment, with the
following criteria:
* At least one hospitalization requiring monitoring in the past two years
(*former patients*)
* Currently healthy or in a stable phase of chronic illness
* 3 volunteers need to have a BMI >30 kg/m2
* 3 volunteers need to live alone (without informal carer)

Exclusion Criteria

* Known allergy/skin irritation to the adhesives used in the sensor patches.
* Implanted active medical devices, such as a cardioverter defibrillator or a
pacemaker
* Current pregnancy
* Inability to give informed consent

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Study 1<br /><br>Primary outcome is the accuracy of the vital sign parameters that each<br /><br>prototype solution measures as compared with the reference standard.<br /><br><br /><br>Study 2<br /><br>The primary outcome measure of study 2 is the usability of each of the<br /><br>prototype solutions, as measured with the system usability scale (SUS).</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The secondary outcome measure of study 2 is the technical feasibility of<br /><br>ambulatory monitoring at home, which will be evaluated with the following<br /><br>metrics:<br /><br><br /><br>* Success rate of data transmission to external server or gateway device,<br /><br>calculated as percentage: [(actual data points captured / intended data points)]<br /><br>o Duration of interrupted monitoring episodes (e.g., data gaps of 15 minutes, 1<br /><br>hour, 8 hours or more)<br /><br>o Frequency of interrupted monitoring episodes (e.g., data gaps)<br /><br>o The level of accessibility of the measured data</p><br>
© Copyright 2025. All Rights Reserved by MedPath